Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome

Journal of the American College of Nutrition

Volumn 31, Issue 5, 2012, Pages 361-368

  Rafraf, Maryam ^a   Mohammadi, Elahe ^b   Asghari Jafarabadi, Mohammad ^c   Farzadi, Laya ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anthropometric measurements; Insulin resistance; Omega 3 fatty acids; Polycystic ovary syndrome; Visfatin

Indexed keywords

ADIPONECTIN; DOCOSAHEXAENOIC ACID; GLUCOSE; ICOSAPENTAENOIC ACID; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ADULT; ANOVULATION; ARTICLE; BODY MASS; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ENDOCRINE DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIRSUTISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC PARAMETERS; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIET; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; IRAN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; POLYCYSTIC OVARY SYNDROME; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84876330262     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2012.10720443     Document Type: Article

References (54)

1. BaptisteCG, BattistaMC, TrottierA, BaillargeonJP: Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol122:42-52, 2010.
2. EhrmannDA: Polycystic ovary syndrome. N Engl J Med352:1223-1236, 2005.
3. DouglasCC, GowerBA, DarnellBE, OvalleF, OsterRA, AzzizR: Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril85:679-688, 2006.
4. OvalleF, AzzizR: Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril77:1095-1105, 2002.
5. PlatiE, KouskouniE, Malamitsi-PuchnerA, BoutsikouM, KaparosG, BakaS: Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. Fertil Steril94:1451-1456, 2010.
6. GlintborgD, AndersenM, HagenC, FrystykJ, HulstromV, FlyvbjergA, HermannAP: Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol155:337-345, 2006.
7. BohlerH, MokshagundamS, WintersSJ: Adipose tissue and reproduction in women. Fertil Steril94:795-825, 2010.
8. Saddi-RosaP, OliveiraCS, GiuffridaFM, ReisAF: Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Synd2:21, 2010.
9. SommerG, GartenA, PetzoldS, Beck-SickingerAG, BluherM, StumvollM, FasshauerM: Visfatin/PBEF/Nampt: Structure, regulation and potential function of a novel adipokine. Clin Sci115:13-23, 2008.
10. SandeepS, VelmuruganK, DeepaR, MohanV: Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism56:565-570, 2007.
11. ChanTF, ChenYL, ChenHH, LeeCH, JongSB, TsaiEM: Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil Steril88:401-405, 2007.
12. PanidisD, FarmakiotisD, RoussoD, KatsikisI, DelkosD, PioukaA, GerouS, Diamanti-KandarakisE: Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur J Intern Med19:406-412, 2008.
13. OzkayaM, CakalE, UstunY, Engin-UstanY: Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome. Fertil Steril93:880-884, 2010.
14. KowalskaI, StraczkowskiM, NikolajukA, AdamskaA, Karczewska-KupczewskaM, OtziomekE, WolczynskiS, GorskaM: Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod22:1824-1829, 2007.
15. ChavarroJE, Rich-EdwardsJW, RosnerBA, WillettWC: Dietary fatty acid intakes and the risk of ovulatory infertility. Am J Clin Nutr85:231-237, 2007.
16. Kasim-KarakasSE, AlmarioRU, GregoryL, WongR, ToddH, LasleyBL: Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. J Clin Endocrinol Metab89:615-620, 2004.
17. PhelanN, ConnorAO, TunTK, CorreiaN, BoranG, RocheHM, GibneyJ: Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebocontrolled, crossover trial. Am J Clin Nutr93:652-662, 2011.
18. OhR: Practical applications of fish oil (omega-3 fatty acids) in primary care. J Am Board Fam Pract18:28-36, 2005.
19. GallagherML: The nutrients and their metabolism. In: Kathleen ML, Escott SS: “Krause’s Food, Nutrition and Diet Therapy,” 12th ed. Philadelphia: WB Saunders, pp 39-143, 2008.
20. BuckleyJD, HowePRC: Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity—a review. Nutrients2:1212-1230, 2010.
21. KabirM, SkurnikG, NaourN, PechtnerV, MeugnierE, RomeS, Quignard-BoulangeA, VidalH, SlamaG, ClementK, Guerre- MilloM, RizkallaAW: Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86:1670-1679, 2007.
22. HarrisWS, MillerM, TigheAP, DavidsonMH, SchaeferEJ: Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis197:12-24, 2008.
23. AnilE: The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype. Proc Nutr Soc66:60-68, 2007.
24. FedorD, KelleyDS: Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care12:138-146, 2009.
25. EbbessonSOE, RisicaRM, EbbessonLOE, KennishJM, TejeroME: Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int J Circumpolar Health64:396-408, 2005.
26. WoodmanRJ, MoriTA, BurkeV, PuddeyIB, WattsGF, BeilinLJ: Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr76:1007-1015, 2002.
27. JainS, GaihaM, BhattacharjeeJ, AnuradhaS: Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress—a prospective preliminary study. J Assoc Physicians India50:1028-1033, 2002.
28. KondoK, MorinoK, NishioY, KondoM, FukeT, UgiS, IwakawaH, KashiwaqiA, MaeqawaH: Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. J Atheroscler Thromb17:628-637, 2010.
29. RossiAS, LombardoYB, LacorteJM, ChiccoAG, RouaultC, SlamaG, RizkallaSW: Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol289:R486-R494, 2005.
30. HajianfarH, HosseinzadehMJ, BahonarA, MohammadK, AskariGR, EntezariMH, KeshavarzA, AnsariN: The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes. J Res Med Sci16:490-495, 2011.
31. Perez-EcharriN, Perez-MatuteP, Marcos-GomezB, MartinezJA, Moreno-AliagaMJ: Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats. Br J Nutr101:1059-1067, 2009.
32. Lorente-CebrianS, BustosM, MartiA, MartinezJA, Moreno- AliagaMJ: Eicosapentaenoic acid stimulates AMP-activated protein kinase and increases visfatin secretion in cultured murine adipocytes. Clin Sci (Lond)117:243-249, 2009.
33. CussonsAJ, WattsGF, MoriTA, StuckeyBG: Omega-3 fatty acid Supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab94:3842-3848, 2009.
34. KajaiaN, BinderH, DittrichR, OppeltPG, FlorB, CupistiS, BeckmannMW, MuellerA: Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome. Eur J Endocrinol157:499-507, 2007.
35. Escobar-MorrealeHF, RoldanB, BarrioR, AlonsoM, SanchoJ, CalleHDL, Garcia-RoblesR: High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab85:4182-4187, 2000.
36. SimopoulosAP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr21:495-505, 2002.
37. MoriTA, BurkeV, PuddeyIB, WattsJF, O’NealDN, BestJD, BeilinLJ: Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr71:1085-1094, 2000.
38. HuangXF, XinX, McLennanP, StorlienL: Role of fat amount and type in ameliorating diet-induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro-opiomelanocortin mRNA expression. Diabetes Obes Metab6:35-44, 2004.
39. FlachsP, Mohamed-AliV, HorakovaO, RossmeislM, Hosseinzadeh- AttarMJ, HenslerM, RuzickovaJ, KopeckyJ: Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia49:394-397, 2006.
40. SneddonAA, TsofliouF, FyfeCL, MathesonI, JacksonDM, HorganG, WinzellMS, WahleKW, AhrenBO, WilliamsLM: Effects of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin. Obesity 16:1019-1024, 2008.
41. HillAM, BuckleyD, MurphyKJ, HowePR: Combining fish-oil Supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr85:1267-1274, 2007.
42. TahvonenRL, SchwabUS, LinderborgKM, MykkanenHM, KallioHP: Black currant seed oil and fish oil Supplements differ in their effects on fatty acid profiles of plasma lipids, and concentrations of serum total and lipoprotein lipids, plasma glucose and insulin. J Nutr Biochem16:353-359, 2005.
43. Navas-CarreteroS, Perez-GranadosAM, SchoppenS, VaqueroMP: An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women. Br J Nutr 102:546-553, 2009.
44. Rasic-MilutinovicZ, PerunicicG, PljesaS, GluvicZ, SobajicS, DjuricI, RisticD: Effects of n-3 PUFAs Supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail29:321-329, 2007.
45. HiguchiT, ShiraiN, SaitoM, SuzukiH, KagawaY: Levels of plasma insulin, leptin and adiponectin, and activities of key enzymes in carbohydrate metabolism in skeletal muscle and liver in fasted ICR mice fed dietary n-3 polyunsaturated fatty acids. J Nutr Biochem19:577-586, 2008.
46. StorlienLH, KriketosAD, JenkinsAB, BaurLA, PanDA, TapsellLC, CalvertGD: Does dietary fat influence insulin action?Ann N Y Acad Sci827:287-301, 1997.
47. FlachsP, RossmeislM, BryhnM, KopeckyJ: Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond)116:1-16, 2009.
48. TsitourasPD, GucciardoF, SalbeAD, HewardC, HarmanSM: High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res40:199-205, 2008.
49. TierneyAC, McMonagleJ, ShawDI, GulsethHL, HelalO, SarisWH, PaniaguaJA, Golabek-LeszczynskaI, DefoortC, WilliamsCM, KarsltromB, VessbyB, Dembinska-KiecA, Lopez-MirandaJ, BlaakEE, DrevonCA, GibneyMJ, LovegroveJA, RocheHM: Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond)35:800-809, 2011.
50. PaniaquaJA, Perez-MartinesP, GjelstadIMF, TierneyAC, Delgado-ListaJ, DefoortC, BlaakEE, RiserusU, DrevonCA, Kiec-WilkB, LovegroveJA, RocheHM, Lopez-MirandaJ: A lowfat high-carbohydrate diet Supplemented with long-chain n-3 PUFA reduces the risk of the metabolic syndrome. Atherosclerosis218:443-450, 2011.
51. ShidfarF, KeshavarzA, HosseyniS, AmeriA, YarahmadiS: Effects of omega-3 fatty acid Supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients. East Mediterr Health J14:305-313, 2008.
52. DogruT, SonmezA, TasciI, BozogluE, YilmazMI, GencH, ErdemG, GokM, BingolN, KilicS, OzgurtasT, BingolS: Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract76:24-29, 2007.
53. TanBK, ChenJ, DigbyJE, KeaySD, KennedyCR, RandevaHS: Increased visfatin mRNA and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome (PCOS): parallel increase in plasma visfatin. J Clin Endocrinol Metab91:5022-5028, 2006.
54. NettletonJA, Katz R: n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc105:428-440, 2005.